title: [Immunologic monitoring of patients with cystic fibrosis: value of different laboratory findings].
abstract: Cystic fibrosis (CF) is a common, serious, and frequently fatal autosomal recessive genetic disorder associated with the poor function of chloride channels. Chronic endobronchial inflammation and bacterial infection are main causes of morbidity and mortality due to CF. The study dealt with a relationship between progression and inflammation markers. Twenty one CF children with acute pulmonary exacerbation were examined. The signs of peripheral blood inflammation (responses of lymphocytes to PHA and their sensitivity to the antiproliferative effect of glucocorticoids) and in situ inflammation markers (sputum elastase activity, IL-8 and TNF-alpha, and protein concentrations in the same sputum specimens). These laboratory findings were used to calculate a "laboratory index" (LI). The clinical status of each patient was evaluated with a "clinical index" (CI), a parameter that includes respiratory secretion cultures, pulmonary function test results, nutritional status, and the presence of disease-related complications. There was a positive linear correlation between LI and CI. The presence of P. aeruginosa was strongly associated with the changes of inflammatory markers. CF patients with prolonged P. aeruginosa infection demonstrated extremely enhanced elastase activity and elevated amounts of sputum IL-8 and TNF-alpha as compared to uninfected subjects. The lung elastase activities, sputum protein contents, and TNF-alpha levels in individuals with short-term colonization were at or below those without P. aeruginosa infection. In patients with or without short-term colonization, the normalization of laboratory parameters was strongly related to evident clinical improvement. At the same time, antibiotic treatment failed to suppress an excessive inflammatory response in the lungs of patients with prolonged P. aeruginosa infection. The importance of individual inflammation markers is discussed in the paper.
authors.forename: L A
authors.initials: LA
authors.lastname: Pevnitskiĭ
authors.forename: A L
authors.initials: AL
authors.lastname: Pukhal'skiĭ
authors.forename: N I
authors.initials: NI
authors.lastname: Kapranov
authors.forename: E A
authors.initials: EA
authors.lastname: Kalashnikova
authors.forename: G V
authors.initials: GV
authors.lastname: Shmarina
authors.forename: D A
authors.initials: DA
authors.lastname: Pukhal'skaia
authors.forename: S N
authors.initials: SN
authors.lastname: Kokarovtseva
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Kashirskaia
authors.forename: L A
authors.initials: LA
authors.lastname: Shabalova
mesh_terms: D000293:Adolescent; D015415:Biomarkers / Q000097:blood; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000276:immunology* / Q000378:metabolism; D018450:Disease Progression; D006801:Humans; D007158:Immunologic Techniques; D007249:Inflammation / Q000276:immunology / Q000378:metabolism; D016209:Interleukin-8 / Q000097:blood* / Q000276:immunology; D010196:Pancreatic Elastase / Q000378:metabolism*; D013601:T-Lymphocytes / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000378:metabolism*
chemical_list: D015415:Biomarkers; D016209:Interleukin-8; D014409:Tumor Necrosis Factor-alpha; D010196:Pancreatic Elastase